Abivax ADR (NASDAQ:ABVX) shares, rose in value on Thursday, April 16, with the stock price up by 1.75% to the previous day’s close as strong demand from buyers drove the stock to $6.40.
Actively observing the price movement in the last trading, the stock closed the session at $6.29, falling within a range of $5.98 and $6.63. The value of beta (5-year monthly) was 1.559. Referring to stock’s 52-week performance, its high was $16.63, and the low was $4.77. On the whole, ABVX has fluctuated by -6.43% over the past month.
With the market capitalization of Abivax ADR currently standing at about $405.89 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-23.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 7.24M, with a low estimate of 3.11M and a high estimate of 3.11M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 3.11M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ABVX’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of ABVX currently trading nearly 2.98% and -4.74% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 52.21, while the 7-day volatility ratio is showing 10.16% which for the 30-day chart, stands at 10.33%. Furthermore, Abivax ADR (ABVX)’s beta value is 0.31, and its average true range (ATR) is 0.62.
A comparison of Abivax ADR (ABVX) with its peers suggests the former has fared considerably weaker in the market. ABVX showed an intraday change of 1.75% in last session, and over the past year, it shrunk by -56.55%%.
Data on historical trading for Abivax ADR (NASDAQ:ABVX) indicates that the trading volumes over the past 10 days have averaged 0.19 and over the past 3 months, they’ve averaged 211.63K. According to company’s latest data on outstanding shares, there are 63.35 million shares outstanding.
Nearly 13.02% of Abivax ADR’s shares belong to company insiders and institutional investors own 35.65% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.62 million shares as on 2025-03-31, resulting in a short ratio of 5.12. According to the data, the short interest in Abivax ADR (ABVX) stood at 316.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 1.23 million. The stock has fallen by -12.57% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ABVX stock heading into the next quarter.
